Investor Relations

Empowering global health innovation through science, integrity, and vision.
Lathell Nutraceuticals LLC is a U.S.-based nutraceutical and functional food company pioneering next-generation health products designed to redefine how the world experiences wellness. From cellular rejuvenation to metabolic balance, every Lathell innovation is built on clinical science, ethical sourcing, and a commitment to measurable human results.
1. Executive Overview
Lathell Nutraceuticals LLC develops, owns, and manages a growing portfolio of advanced nutraceutical formulations and global health brands. Our mission is to create safe, natural, and clinically backed solutions for the world’s most urgent health challenges — from diabetes and kidney disease to cognitive decline and longevity.
The company’s breakthrough sweetener platform, SAFE SUGAR™, represents a new category of sugar — one that behaves like sugar in taste and texture, but acts like a metabolic ally inside the body. Through its dedicated subsidiary, Safe Sugar SPV LLC, Lathell is structuring international commercialization, licensing, and investment opportunities around this breakthrough technology.
2. The Investment Opportunity
The world is shifting toward natural, science-driven wellness solutions. Global nutraceutical demand exceeds $500 billion, and clean-label, functional, and metabolic health products are the fastest-growing segments. Lathell is positioned at the intersection of this movement.
Our formulations are developed for high scalability, IP protection, and strong health credibility — each backed by real scientific mechanisms and market validation. Investors gain entry into a multi-brand, multi-market growth platform built to evolve with emerging scientific and consumer trends.
3. Market Position and Advantages




4. Product Portfolio Highlights
SAFE SUGAR™ – Gut-friendly, very low-glycemic natural sugar alternative under regulatory review.

SAFE SALT™ – Reduced-sodium, heart-safe mineral salt that preserves natural flavor while supporting blood pressure balance.
5. Traction and Milestones





Next milestones include international licensing expansion, clinical validation, and co-manufacturer scaling under cGMP.
6. Financial Overview
Lathell Nutraceuticals operates with a lean, scalable structure. Safe Sugar SPV LLC functions as a dedicated investment vehicle for the sweetener line, enabling transparent investor participation and royalty-based licensing structures.
Use of Funds:



Exit Strategy:
Strategic acquisition, licensing, or IPO positioning following market validation.
7. Leadership and Structure
Lathell Sancho – Founder & CEO
A visionary leader focused on combining science, consciousness, and biotechnology to redefine wellness.
Lathell Nutraceuticals LLC serves as the parent company. Subsidiaries such as Safe Sugar SPV LLC operate as dedicated vehicles for brand-specific ownership, investor participation, and international rights management.
8. Legal and Compliance
Lathell Nutraceuticals LLC and its subsidiaries are registered in Wyoming, USA, with a strong legal foundation for IP protection, NDAs, and confidential investor participation.
All brand trademarks, formulas, and IP assets are owned or assigned under Lathell Nutraceuticals LLC or its respective SPVs. Investor documents are prepared in compliance with U.S. private-offering and cross-border investment regulations.
9. Contact for Investors
Lathell Nutraceuticals LLC
30 N Gould St Ste N, Sheridan, WY 82801
Email: investors@safesugarhq.com
Phone/WhatsApp: +1 (702) 413-4481
Website: www.safesugarhq.com
Join us in building the future of global health.
Every investment accelerates a future where science, safety, and nature converge to improve human longevity and quality of life.
© 2025 Safe Sugar LLC — a wholly owned subsidiary of Lathell Nutraceuticals LLC. 30 N Gould St, Ste N, Sheridan, WY 82801 • ops@safesugarhq.com • +1 (702) 413-4481
The Planned Safe Sugar HQ Campus – A Foundation for Future Growth
© 2025 Safe Sugar SPV LLC – All Rights Reserved.
This page is for informational purposes only and does not constitute an offer to sell securities or a guarantee of regulatory status or outcomes.
A Lathell Nutraceuticals Company